Scientists at Duke University, North Carolina have begun investigating the effect of cord blood on sufferers of adult stroke. 100 patients between 18-90 years of age will undergo umbilical cord blood transfusions between 3 and 10 days after their stroke. They will...
A ground-breaking trial has been announced in the USA at the Children’s Hospital Los Angeles with the aim of helping babies born with a heart defect. Dr. Ram Kuma Subramanyan, a Cardiothoracic Surgeon at the CHLA explained: “About two or three decades ago, this...
In the USA, the Food & Drug Authority (FDA) has given permission to Duke University Medical Center to offer cord blood therapy to children with neurological conditions including: Autism spectrum disorder Autism Cerebral palsy Hydrocephalus Apraxia of speech...
The American Heart Association has recently published results of a study that saw patients with heart failure receive an intravenous infusion of umbilical cord stem cells. The study comprised of 30 patients aged 18 – 75 who had stable heart failure. Participants were...
In early July 2017 a panel of cancer experts unanimously endorsed CAR-T treatment for leukaemia. With FDA approval expected, it will become the first gene therapy to reach the market creating a ‘living drug’ that genetically alters a patients own cells to fight...
An estimated 1 in 100 children(1) in the UK have some form of autism and currently four times more boys are diagnosed with the condition than girls.(2) Autism is a spectrum disorder meaning that the symptoms are broad and vary greatly in severity. However they include...
Stem Cell Therapy Potential for Duchenne Muscular Dystrophy
